Wisconsin Alumni Research Foundation

Research Tools
Research Tools
SufFeSient Cells
WARF: P190138US01

Inventors: Patricia Kiley, Erin Mettert

The Wisconsin Alumni Research Foundation is seeking commercial partners interested in developing an improved derivative of E. coli strain BL21 ╬╗DE3, which is commonly used for inducibly overexpressing recombinant proteins
Overview
The commercially available E. coli strain BL21 λDE3 is commonly used for inducibly overexpressing recombinant proteins. Many derivatives of BL21 cells have been developed and commercialized, with properties that enhance the options for inducing and controlling expression, reducing leak expression, and much more. However, BL21 λDE3 is not optimized for purification of some proteins containing Fe-S cluster cofactors that are synthesized by proteins of the Suf Fe-S cluster biogenesis pathway. Fe-S proteins are found throughout the biological world and possess various catalytic activities and are the bottlenecks to produce many products; therefore, in this present optimized strain (PK11466) has improved the purification yield of at least two different Fe-S cluster-containing proteins. 
The Invention
UW-Madison researchers have developed an improved derivative of the overexpression strain BL21 λDE3. The new cell strain is called PK11466 and was nicknamed ‘SufFeSient cells’ by a collaborator. The researchers founds that BL21 λDE3 has an 854 bp deletion within the sufABCDSE operon that encodes for the Suf proteins; the deletion encompasses portions of sufA and sufB. They created the improved strain derivative by constructing a functional sufABCDSE operon. Furthermore, they modified the promoter of the reconstructed sufABCDSE operon to provide increased and constitutive expression. As a result, they found that overexpressed Fe-S cluster-containing proteins had better cluster occupancy and better yield for the overexpressed product.
Applications
  • Improved derivative of the overexpression strain BL21 λDE3
Key Benefits
  • Could improve the production of many proteins (regardless of Fe-S content), by enhancing the yield and activity of key Fe-S cluster containing enzymes necessary to produce the target protein or product
  • Improved purification of at least two different Fe-S cluster-containing proteins
Additional Information
For More Information About the Inventors
For current licensing status, please contact Mark Staudt at [javascript protected email address] or 608-960-9845

WARF